Dr Qian Yuan, a distinguished physician-scientist, has embarked on an ambitious journey that bridges athletic endurance and scientific discovery. In a bold display of commitment, Dr Yuan is attempting to complete all seven World Marathon Majors within a single year. This endeavor is not merely a personal milestone but a strategic mission to raise awareness and vital funds for the Food Allergy Science Initiative (FASI), a nonprofit dedicated to advancing the diagnosis and treatment of food allergies.
The scope of this challenge is global, mirroring the widespread impact of the disease Dr Yuan fights in the lab and the clinic. His 2026 marathon effort includes races such as Tokyo, Boston, and other major international events. Dr Yuan describes the grueling nature of the sport as a reflection of his professional drive, noting that running a marathon has been a life-changing and transformative experience—one that challenges him physically and mentally while providing an opportunity to support causes related to children’s health and well-being.
The motivation behind this demanding schedule is the ongoing challenge posed by food allergies. Food allergies affect an estimated 32 million Americans, and prevalence continues to rise as researchers work to better understand the underlying causes. For many families, management still relies on strict avoidance of trigger foods and the use of emergency epinephrine. Dr Yuan emphasizes the importance of continued research, noting that food allergies are both his clinical and research focus and that a deeper understanding of their underlying mechanisms is essential to developing improved prevention strategies and treatments.
The Food Allergy Science Initiative (FASI) serves as the beneficiary of Dr Yuan’s efforts. FASI operates as a discovery engine, bringing together experts from fields such as neuroscience, immunology, and computational biology. By breaking down traditional silos between disciplines, the organization aims to uncover why the immune system mistakenly identifies certain foods as threats, with the ultimate goal of moving beyond management toward long-term solutions.
Leadership at FASI has lauded Dr Yuan’s dual commitment to his patients and the broader scientific community. Carlos Bosques, CEO of FASI, said Yuan reflects the best of what the organization hopes to see in the field—a clinician and scientist deeply committed to improving the lives of patients. Similarly, Christine Olsen, MD, co-founder of FASI, highlighted that his journey underscores a deep commitment to advancing the field and bringing hope to families.
Public education remains a cornerstone of Dr Yuan’s marathon campaign. He believes that increasing public understanding of the biological complexities of food allergies will help build support for the research needed to address them. He emphasizes the importance of helping people better understand why and how food allergies occur, pointing to the current era of research as a potential turning point.
As Dr Yuan prepares for the upcoming legs of his journey, his message remains one of optimism and perseverance. He maintains that the path to better treatments—and ultimately prevention—requires long-term dedication. He points to ongoing, cutting-edge research, including work supported by FASI, as a source of real hope for the future.
We urge you to support Dr Yuan in his efforts to raise money for continued research into therapies and a cure for food allergy with a donation to FASI.
